stage IV chronic lymphocytic leukemia
Showing 9976 - 10000 of >10,000
Traumatic Brain Injury Trial in Houston (HB-adMSCs)
Active, not recruiting
- Traumatic Brain Injury
- HB-adMSCs
-
Houston, TexasMemorial Hermann Hospital-Clinical Research Unit (MMH-CRU)
May 27, 2022
Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7, Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7, Stage IVB
Recruiting
- Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7
- +2 more
- Intensity-Modulated Radiation Therapy
- +4 more
-
Birmingham, Alabama
- +21 more
May 13, 2022
Chronic Pain Trial in Pittsburgh (Occupational Therapy, Occupational Therapy +Virtual Reality)
Recruiting
- Chronic Pain
- Occupational Therapy
- Occupational Therapy +Virtual Reality
-
Pittsburgh, PennsylvaniaUPMC Centers for Rehab Services Centre Commons
Apr 18, 2022
Leukemia Trial in Houston (Cladribine, Cytarabine, Decitabine)
Recruiting
- Leukemia
- Cladribine
- +2 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Aug 23, 2022
Parkinson Disease Trial in San Jose, New York (Occupational therapy intervention group, Disease management education group)
Recruiting
- Parkinson Disease
- Occupational therapy intervention group
- Disease management education group
-
San Jose, California
- +1 more
Apr 25, 2022
Advanced Rectal Cancer, Distal Metastasis Trial in Shanghai (a combination therapy)
Not yet recruiting
- Advanced Rectal Cancer
- Distal Metastasis
- a combination therapy including tislelizumab
-
Shanghai, Shanghai, ChinaXinxiang Li
Nov 12, 2022
Type 1 Diabetes, Hypoglycemia Trial in Toronto (ZT-01 low dose, ZT-01 high dose, Placebo)
Terminated
- Type 1 Diabetes
- Hypoglycemia
- ZT-01 low dose
- +2 more
-
Toronto, Ontario, CanadaLMC Manna Research
May 12, 2022
T-cell Leukemia/Lymphoma, Refractory T Lymphoblastic Leukemia/Lymphoma, Relapse/Recurrence Trial in Beijing (chimeric antigen
Recruiting
- T-cell Leukemia/Lymphoma
- +2 more
- chimeric antigen receptor T cell treatment
-
Beijing, Beijing, ChinaBeijing Boren Hospital
Jul 31, 2022
Squamous Cell Carcinoma Trial in Pittsburgh (Pembrolizumab Injection)
Recruiting
- Squamous Cell Carcinoma
- Pembrolizumab Injection
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Jun 21, 2022
Epigenomic Dysregulation in Preeclampsia-Associated Chronic
Completed
- Preeclampsia
- +2 more
-
Columbus, OhioThe Ohio State University
Oct 10, 2022
COPD, Emphysema, Emphysema or COPD Trial (dual anti-platelet therapy, Placebo)
Not yet recruiting
- COPD
- +2 more
- dual anti-platelet therapy
- Placebo
- (no location specified)
Oct 9, 2022
Time Restricted Feeding, Renal Insufficiency, Chronic, Obesity Trial in Guangzhou (Time-restricted feeding(TRF))
Completed
- Time Restricted Feeding
- +2 more
- Time-restricted feeding(TRF)
-
Guangzhou, Guangdong, ChinaGuangdong Provincial Hospital of Chinese Medicine
Jul 2, 2022
Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer Trial in Kansas City (HIPEC, Carboplatin, Paclitaxel)
Recruiting
- Ovarian Cancer
- +2 more
- HIPEC
- +2 more
-
Kansas City, KansasThe University of Kansas Cancer Center
Jan 21, 2022
Prevention of Influenza Trial in Ghent (Seasonal,quadrivalent,influenza vaccine)
Completed
- Prevention of Influenza
- Seasonal,quadrivalent,influenza vaccine
-
Ghent, East-Flanders, BelgiumUniversity Hospital - Center for Vaccinology
Jan 21, 2022
Heart Failure, Heart Diseases, Cardiovascular Diseases Trial in Kansas City (Heat Therapy Treatment)
Completed
- Heart Failure
- +3 more
- Heat Therapy Treatment
-
Kansas City, KansasUniversity of Kansas Medical Center
Oct 12, 2022
Alcohol Use Disorder Trial in Indianapolis (Low frequency repetitive transcranial magnetic stimulation (rTMS), Sham)
Recruiting
- Alcohol Use Disorder
- Low frequency repetitive transcranial magnetic stimulation (rTMS)
- Sham
-
Indianapolis, IndianaNeural Systems Lab
Jul 5, 2022
Myopia Trial in Shanghai (1% atropine 5+3)
Recruiting
- Myopia
- 1% atropine 5+3
-
Shanghai, Shanghai, ChinaShanghai Eye Diseases Prevention & Treatment Center
Jul 11, 2022
Chronic Pain, Chronic Pain Syndrome Trial in Boston (Mind Body Intervention 1, Mind Body Intervention 2)
Completed
- Chronic Pain
- Chronic Pain Syndrome
- Mind Body Intervention 1: Mind-Body-Syndrome-Therapy (MBST)
- Mind Body Intervention 2
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Jan 10, 2023
Multiple Myeloma Trial in Worldwide (Eftozanermin alfa, Bortezomib, Dexamethasone)
Active, not recruiting
- Multiple Myeloma
- Eftozanermin alfa
- +2 more
-
Atlanta, Georgia
- +18 more
Oct 12, 2022
Pain Syndrome Trial in ALMinya (Dexamethasone, Midazolam injection)
Completed
- Pain Syndrome
- Dexamethasone
- Midazolam injection
-
ALMinya, EgyptMina Maher Raouf
Feb 14, 2022
Acute Exacerbations of Chronic Obstructive Pulmonary Disease in
Active, not recruiting
- Pulmonary Disease, Chronic Obstructive
- Prospective observational cohort study
-
Fukuoka, Japan
- +12 more
Apr 4, 2022
Severe Combined Immunodeficiency (SCID), Immunodeficiency With Predominant T-cell Defect, Unspecified, Severe Chronic
Enrolling by invitation
- Severe Combined Immunodeficiency (SCID)
- +8 more
- CD3/CD19 negative allogeneic hematopoietic stem cells
-
Pittsburgh, PennsylvaniaChildren's Hospital of Pittsburgh of UPMC
Dec 6, 2021
Kidney Failure, End Stage Renal Disease, Hypotension Trial in Ann Arbor (Patient Activation, Provider Education)
Suspended
- Kidney Failure
- +4 more
- Patient Activation
- Provider Education
-
Ann Arbor, MichiganFresenius Kidney Care University Of Michigan - Ann Arbor
Nov 22, 2021